Renal and cardiac assessment of living kidney donor candidates
Nature Reviews Nephrology 13, 420 (2017). doi:10.1038/nrneph.2017.43 Authors: Ngan N. Lam, Krista L. Lentine &Amit X. Garg Living kidney donation provides the best therapeutic outcomes for eligible patients with end-stage renal disease. To ensure suitability for living kidney donation, donor candidates undergo a thorough medical, surgical, and psychosocial evaluation by a multidisciplinary transplant assessment team. Numerous guidelines are available to assist clinicians
CONCLUSION: The etiological diagnosis of hereditary urinary lithiasis in our study was made with considerable delay. Cystinuria was the most frequent etiology and primary hyperoxaluria was the most serious affection. LEVEL OF EVIDENCE: 4. PMID: 31537493 [PubMed - as supplied by publisher]
Publication date: September 2019Source: European Urology Supplements, Volume 18, Issue 6Author(s): R. De Groote, E. De Bleser, S. Chintzoglou, P. Sooriakumaran, S. Nathan
Publication date: September 2019Source: European Urology Supplements, Volume 18, Issue 6Author(s): V. Dassi, A. Kumar, S.Y. Qadri
Conclusions: Tacrolimus therapeutic drug monitoring improved treatment outcomes of Chinese alloHSCT recipients. Cv measurements during weeks 3–4 and C0 or C2 measurements during weeks 5–6 better predicted aGVHD (I–IV) than the concentrations measured at other time points during the first 6 weeks after alloHSCT.
No abstract available
This Viewpoint uses provisions in President Trump ’s 2019 American Kidney Health Executive order calling for an increase in access to kidney transplantation to discuss strategies to increase deceased and living donor pools, improve allocation of organs from higher-risk donors, and support the long-term medical needs of living donors.
To describe the surgical technique for single-port robotic extraperitoneal dual kidney transplantation (DKT) using the SP ® surgical system (Intuitive Surgical, Sunnyvale, CA, USA) in a pre-clinical model.
ConclusionsIn ACLF patients with either no or small esophageal varices and HVPG ≥ 12 mmHg, carvedilol leads to improved survival and fewer AKI and SBP events up to 28 days.ClinicalTrials.gov identifier numberNCT02583698.
A 50-year-old woman underwent living-related kidney transplant 7 years ago. She developed an episode of acute T-cell –mediated rejection 2 years ago, which was treated with steroids. Her serum creatinine recently increased to 9 mg/dl after she stopped taking her immunosuppressive medications and a biopsy was performed.
The ISN and Kidney International recently introduced the ISN-KI Editorial Fellowship, which is designed specifically for early career researchers working within the field of nephrology, dialysis, and kidney transplantation. The purpose of this Fellowship is to provide training opportunities for the review and critical evaluation of manuscripts and the management of editorial responsibilities within the context of a high-impact nephrology journal. We are delighted and proud to announce the 2 winners of our 2019 Fellowships.